GENE ONLINE|News &
Opinion
Blog

Cancer
Trials & Approvals Colorectal Cancer
Priority Review of Seagen’s Colorectal Cancer Treatment Wins FDA Acceptance
2022-09-19
R&D human embryos
Is Frozen-Thawed Embryo Transfer Associated with Increased Cancer Risk?
2022-09-16
Funding Series D Funding
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Trials & Approvals Oncology
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
Special Oncology
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Trials & Approvals European Commission
Kyowa Kirin’s Treatment for a Rare Cancer Disorder Approved by European Commission
2022-08-19
Trials & Approvals Bayer
Bayer, Orion’s Prostate Cancer Drug Gets Approval For Second Indication
2022-08-10
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
Trials & Approvals CancerClinical Trial
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
Trials & Approvals Cancer ImmunotherapyRoche
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
Trials & Approvals AstraZenca
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Trials & Approvals Clinical TrialCancer
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
Technology CDO
Taiwan’s CancerFree Bio Showcases World’s First Commercialized Personalized Cancer Profile
2022-08-01
Trials & Approvals Cancer
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Trials & Approvals Oncology
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
1 2 3 4 … 22
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top